Sumant Raghavendra Pargaonkar

Dr. Sumant Raghavendra Pargaonkar

Internal Medicine, Jacobi Medical Center, New York, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
AKAmrin Kharawala
Amrin Kharawala
SNSanjana Nagraj
Sanjana Nagraj
JSJiyoung Seo
Jiyoung Seo
SPSumant Raghavendra Pargaonkar
Sumant Raghavendra Pargaonkar
MUMayuko Uehara
Mayuko Uehara
UJUlrich Jorde
Ulrich Jorde
Orthotopic heart transplant is the gold standard therapeutic intervention for patients with end-stage heart failure. Conventionally, heart transplant has relied on donation after brain death for organ recovery. Donation after circulatory death (DCD) is the donation of the heart after confirming that circulatory function has irreversibly ceased. DCD-orthotopic heart transplant differs from donation after brain death-orthotopic heart transplant in ways that carry implications for widespread adoption, including differences in organ recovery, storage and ethical considerations surrounding normothermic regional perfusion with DCD. Despite these differences, DCD has shown promising early outcomes, augmenting the donor pool and allowing more individuals to benefit from orthotopic heart transplant. This review aims to present the current state and future trajectory of DCD-heart transplant, examine key differences between DCD and donation after brain death, including clinical experiences and innovations in methodologies, and address the ongoing ethical challenges surrounding the new frontier in heart transplant with DCD donors.

6 November 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
David-Dimitris ChlorogiannisDavid-Dimitris Chlorogiannis
David-Dimitris Chlorogiannis
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
ACAnargyros Chlorogiannis
Anargyros Chlorogiannis
LPLeonidas Palaiodimos
Leonidas Palaiodimos
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
Cardiovascular and cerebrovascular disease incidence has risen mainly due to poor control of preventable risk factors and still constitutes a significant financial and health burden worldwide. ChatGPT is an artificial intelligence language-based model developed by OpenAI. Due to the model’s unique cognitive capabilities beyond data processing and the production of high-quality text, there has been a surge of research interest concerning its role in the scientific community and contemporary clinical practice. To fully exploit ChatGPT’s potential benefits and reduce its possible misuse, extreme caution must be taken to ensure its implications ethically and equitably. In this narrative review, we explore the language model’s possible applications and limitations while emphasizing its potential value for diagnosing, managing, and prognosis of cardiovascular and cerebrovascular disease.

8 April 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
DVDimitrios Varrias
Dimitrios Varrias
TSTinatin Saralidze
Tinatin Saralidze
PBPawel Borkowski
Pawel Borkowski
SPSumant Raghavendra Pargaonkar
Sumant Raghavendra Pargaonkar
Michail SpanosMichail Spanos
Michail Spanos
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
Numerous longitudinal studies suggest a strong association between cardiovascular risk factors and cognitive impairment. Individuals with atrial fibrillation are at higher risk of dementia and cognitive dysfunction, as atrial fibrillation increases the risk of cerebral hypoperfusion, inflammation, and stroke. The lack of comprehensive understanding of the observed association and the complex relationship between these two diseases makes it very hard to provide robust guidelines on therapeutic indications. With this review, we attempt to shed some light on how atrial fibrillation is related to dementia, what we know regarding preventive interventions, and how we could move forward in managing those very frequently overlapping conditions.

5 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
David-Dimitris ChlorogiannisDavid-Dimitris Chlorogiannis
David-Dimitris Chlorogiannis
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
ACAnargyros Chlorogiannis
Anargyros Chlorogiannis
LPLeonidas Palaiodimos
Leonidas Palaiodimos
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
Cardiovascular and cerebrovascular disease incidence has risen mainly due to poor control of preventable risk factors and still constitutes a significant financial and health burden worldwide. ChatGPT is an artificial intelligence language-based model developed by OpenAI. Due to the model’s unique cognitive capabilities beyond data processing and the production of high-quality text, there has been a surge of research interest concerning its role in the scientific community and contemporary clinical practice. To fully exploit ChatGPT's potential benefits and reduce its possi-ble misuse, extreme caution must be taken to ensure its implications ethically and equitably. In this article, we explore the language model's possible applications and limitations while empha-sizing its potential value for diagnosing, managing, and prognosis cardiovascular and cerebro-vascular disease.

11 December 2023 in Vasa
Verified
Journal Article
Closed access
David-Dimitris ChlorogiannisDavid-Dimitris Chlorogiannis
David-Dimitris Chlorogiannis
SPSumant Raghavendra Pargaonkar
Sumant Raghavendra Pargaonkar
PPPanagiotis Papanagiotou
Panagiotis Papanagiotou
NBNikolaos C. Bakogiannis
Nikolaos C. Bakogiannis
CBChristos Bakoyiannis
Christos Bakoyiannis
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
Summary: Cardiovascular disease is a major cause of morbidity and mortality worldwide. In the last few years, the role of inflammation and inflammatory modulatory medications is investigated for the optimal treatment of coronary artery disease. It can be hypothesized that since inflammation is also involved in carotid artery stenosis development and progression, the same class of medication could be useful. Our objective with this review is to present the available evidence, published studies and promising ongoing trials on the role of anti-inflammatory medications – with a special emphasis on the most commonly used drug of this class: colchicine – in patients with carotid artery stenosis.

Verified
Journal Article
Open access
PDF file
David-Dimitris ChlorogiannisDavid-Dimitris Chlorogiannis
David-Dimitris Chlorogiannis
SPSumant Raghavendra Pargaonkar
Sumant Raghavendra Pargaonkar
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
NVNikolaos Vythoulkas-Biotis
Nikolaos Vythoulkas-Biotis
DKDamianos G. Kokkinidis
Damianos G. Kokkinidis
SNSanjana Nagraj
Sanjana Nagraj
As the prevalence of cardiovascular disease continues to increase, early identification of patients at high risk of major adverse cardiovascular events (MACE) using reliable diagnostic modalities is important. Transcatheter aortic valve implantation (TAVI) is a minimally invasive percutaneous procedure used to replace the aortic valve with a bioprosthetic one, often without the need for surgery. Extra coronary calcification in the ascending and/or descending thoracic aorta, aortic arch, and abdominal aorta has recently been identified as a method to quantify the extent of atherosclerotic cardiovascular disease. However, its definitive role in the prediction of MACE remains unclear. We performed a comprehensive review to summarize the current literature on the diagnostic and predictive value of thoracic and abdominal aortic calcification, as quantified in computed tomography, for the association, risk stratification, and prediction of MACE and after TAVI procedures. Despite increasing evidence, the predictive role of thoracic calcification still remains unproven, with a need for carefully tailored studies to confirm these findings.